BRÈVE publiée le 27/06/2024 à 16:05, il y a 1 année 8 mois Neuro20 Sparks Hope for Long COVID Recovery Long Covid Clinical Trials Neuro20 FDA-approved Device Patient Improvement
BRÈVE publiée le 27/06/2024 à 16:05, il y a 1 année 8 mois Neuro20 suscite l’espoir d’une longue guérison suite au COVID Essais Cliniques Longue COVID Neuro20 Appareil Approuvé Par La FDA Amélioration Des Patients
COMMUNIQUÉ DE PRESSE publié le 27/06/2024 à 16:00, il y a 1 année 8 mois Neuro20 Sparks Hope for Long COVID Recovery Neuro20 Technologies Corp. releases White Paper on patient improvements and potential mechanisms for Long COVID, showcasing the efficacy of their FDA-cleared wearable muscle stimulation device Wearable Device Long Covid White Paper Neuro20 Technologies Corp. FDA Cleared
Publié le 04/03/2026 à 23:50, il y a 8 heures 45 minutes Capital et droits de vote au 28 février 2026
Publié le 04/03/2026 à 23:00, il y a 9 heures 35 minutes Pinetree Capital Ltd Announces Audited Financial Results for the Year Ended December 31, 2025 and Director Appointment
Publié le 04/03/2026 à 22:55, il y a 9 heures 40 minutes Pacific Avenue Capital Partners Completes Acquisition of U.S. Power Chain Hoist and Chain Business from Columbus McKinnon and Launches New Standalone Company, Stuart Rush
Publié le 04/03/2026 à 22:45, il y a 9 heures 50 minutes Viemed Healthcare Announces Record 2025 Financial Results
Publié le 04/03/2026 à 22:40, il y a 9 heures 55 minutes Stabilis Solutions Announces Fourth Quarter and Full Year 2025 Results
Publié le 05/03/2026 à 08:05, il y a 30 minutes Absa and Thunes unveil Absa Global Pay, a next-generation solution for fast, affordable global remittances
Publié le 05/03/2026 à 08:00, il y a 35 minutes RM plc: Final Results for the year ended 30 November 2025
Publié le 05/03/2026 à 08:00, il y a 35 minutes Pyrum receives ISCC EU certification for thermolysis oil – End-of-life tire recycling becomes biofuel-compatible and strengthens Europe's more resilient raw material and energy supply
